Author:
Elicer Isabel,Eugenin Laura,Acuña María Paz,Uslar Wilhelm,Fernández Ana,Lasso Martin
Reference45 articles.
1. Rajasingham R., Smith R.M., Park B.J., Jarvis J.N., Govender N.P., Chiller T.M., et al. Global Burden of Disease of HIV-Associated Cryptococcal Meningitis: an Updated analysis. Lancet Infect Dis [Internet]. 2017 [citado 29 de junio de 2020];17:873-81. Recuperado a partir de: https://linkinghub.elsevier.com/retrieve/pii/S1473309917302438.
2. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy;Kambugu;Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am.,2008
3. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis;Boulware;N. Engl. J. Med.,2014
4. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy;Williamson;Nat. Rev. Neurol.,2017
5. Cryptococcal meningitis--a neglected killer;Jarvis;South Afr. Med J. Suid-Afr. Tydskr. Vir. Geneeskd.,2011